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The field of tissue engineering (TE) has greatly evolved over the past decade.
1-3
 
The combination of life science principles and engineering technologies have been the 
foundation for the development of biological substitutes that recreate functional, healthy 
tissues and organs previously injured or lost due to trauma and disease.
2,4-6
 
Dentistry has made significant progress towards implementing TE-based 
procedures to repair and regenerate tissues of vital importance to the oral maxillofacial 
complex. The use of tissue scaffolds, bone grafting materials, and oftentimes the local 
delivery of a great variety of cytokines and growth factors, have been able to some 
extent, to regenerate distinct dental-related tissues.
2,4,7-12
  
Although the field of endodontics has been aware that healthy pulp tissue exists 
within the infected/inflamed pulp, resective therapy, i.e. pulpectomy/pulpotomy, has been 
the standard of care, and few attempts have been made to repair the infected pulp. In 
recent years the revascularization technique has changed the treatment of the necrotic 
immature tooth, and such teeth are now able to continue normal root development both in 
length and in width (maturogenesis).
13
  In brief, the root canal system (RCS) is 
disinfected by using irrigation solutions with minimal to no instrumentation followed by 
the application of a triple antibiotic paste (TAP) consisting of metronidazole, 
ciprofloxacin, and minocycline. After 3 to 4 weeks, the tooth is re-entered and the TAP is 
removed with irrigation solution; then, the root canal space is dried and minimally 
instrumented beyond the apex to induce bleeding for the formation of a blood clot in the 
canal.
14
  With bleeding, endogenously produced growth factors and stem cells from the 
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periapical tissues populate the fibrin-based natural scaffold inducing the regeneration 
process.
8,9
  The blood clot serves as a natural scaffold (i.e., fibrin) that aids with new 
tissue formation and root maturogenesis.
14
 The natural scaffold offers host acceptance, 
because it is the patient’s own blood, and the scaffold also reduces the chances of an 
outside pathogen entering the canal space. In medicine, tissue engineering does not rely 
on blood clot formation because the distribution and composition of cells is 
unpredictable. This is a critical limitation to the blood clot. Due to these shortcomings, 
research is being done to investigate artificial scaffolds.
4,8
 
Research is directed toward improving all areas of the revascularization process 
with scaffolds being of significant importance. This requires materials to act as scaffolds 
that could be more desirable than the natural blood clot because obtaining an adequate 
blood clot may be a problem given the variability in blood clot quality.
9,15-17
  In general, 
the properties of an ideal scaffold (natural or synthetic) are biocompatibility, 
biodegradability, and the display of a three-dimensional porous structure. The latter  
mimics the extracellular matrix that is able to provide a spatially correct structure with 
adequate mechanical properties to support new pulp tissue formation, by supporting cell 
differentiation, growth, and sustained angiogenesis.
8
  Furthermore, the scaffold should be 
able to degrade at a similar rate to that of new tissue formation.
18,19
   Natural scaffolds 
include collagen, glycosaminoglycans, demineralized or native dentin matrix, and fibrin. 
Synthetic materials encompass biodegradable and biocompatible polymers such as 
poly(DL-lactide-co-glycolide) (PLGA), poly(lactic acid) (PLA), poly(glycolic acid) 
(PGA), and poly(caprolactone) (PCL) among others.
3,7
 These materials have proven to be 
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capable of supporting the growth of many different cell types
3,7,14
 and may also control 
infection by facilitating the release of antimicrobial agents.
19,20
  
High-voltage driven electrospinning is a facile, nanotechnology-enabled 
technique to fabricate synthetic nanofibrous scaffolds mimicking closely the 
morphological nanofeatures of native extracellular matrix (ECM). In the electrospinning 
process, a generated electrical field produces solid fibers from a polymer-based solution 
(Figure 1). Numerous researchers have proposed the use of the electrospinning method to 
fabricate biologically active scaffolds, i.e., scaffolds incorporated with therapeutic drugs 
and growth factors, aiming to assist in both the healing and regeneration processes. 
Another advantage of the drug delivery system in nanofibrous scaffold is the possibility 
of delivering uniform and highly controlled drug doses at the root canal system via the 
high surface area to volume ratio of the nanofiber system.
  
The ability to incorporate 
drugs into a synthetic matrix may have implications for regenerative endodontics. 
Scaffolds could be made to incorporate antimicrobial properties in the form of antibiotics, 
and this might improve healing and regeneration of dental tissues (pulp and root). 
 
The electrospinning technique was used to generate antimicrobial-containing 
scaffolds. Nano-microfibrous polymer-based scaffolds were obtained from a 
polydioxanone solution (PDS II).  Metronidazole (MET), an antibiotic that is part of TAP 
for disinfection used in the revascularization method, was directly mixed at two distinct 
concentrations (5 wt % and 25 wt %) with the PDS solution and co-electrospun in order 
to obtain the different scaffolds. Metronidazole is known to be effective against gram-
negative anaerobes. It has also been shown that MET is effective in the periodontal 
tissues.
21
  The antibacterial properties of the manufactured scaffold were examined 
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against Porphyromonas gingivalis, a known microorganism associated with primary 
endodontic infections
22-24
 and which served as the test bacterium for the antibacterial 
properties of the manufactured scaffold. 
Antimicrobial properties of restorative materials have 
25
been evaluated in vitro 
using various methodologies. The agar diffusion test (ADT) was the standard assay used 
in most of these studies despite its known limitations. Problems associated with the ADT 
include its qualitative nature, ability to measure only soluble components, inability to 
distinguish between bacteriostatic and bactericidal effects, and difficulties in comparing a 
large number of samples with a large number of variables.
26
 Alternatively, the direct 
contact test (DCT)
27-29
 has been used to quantitatively measure the antimicrobial effect of 
direct and close contact between the test microorganism and the material being tested. It 
is based on turbidimetric measurements of bacterial growth that is, more turbidity 
correlates with more bacterial growth.  A 96-well microtiter plate was used and the 
results are independent of the solubility and diffusibility of the dental material being 
tested
26
 We modified the well-known direct contact test to evaluate the antibacterial 
properties of the drug-containing electrospun scaffolds. The aim of this study was to 
evaluate the in-vitro property of a synthetic polymer scaffold to function as an 
antibacterial drug delivery device. The goal was to determine if there would be 
significant bacterial inhibition using a metronidazole-containing scaffold. 
 
CLINICAL SIGNIFICANCE 
Electrospinning is a nanotechnology that can fabricate synthetic scaffolds that 
mimic the morphological nanofeatures of the native extracellular matrix. For regenerative 
endodontics, the use of this technology is a novel idea and has not yet been done. 
6 
 
Utilizing the high surface area to volume ratio of the nanofiber system, it could be made 
into an effective matrix satisfying the ideal properties needed of a scaffold by controlling 
drug dose and concentration while supporting cell growth in a spatially stable porous 
environment ideal for the regeneration process. 
 
HYPOTHESES 
 
 
Null Hypothesis  
P. gingivalis would be significantly inhibited by the drug release from the MET-
containing PDS electrospun scaffolds. 
 
Alternate Hypothesis 
P. gingivalis would not be significantly inhibited by the drug release from the 
MET-containing PDS electrospun scaffolds. 
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HISTORY OF ENDODONTICS  
Since the beginning of endodontics in the 17
th
 century, there have been significant 
advances for the improvement of endodontic diagnosis, treatment, and outcomes.
30
  
Charles Allen in 1687 detailed the technique of dental transplants as being “taking out the 
rotten teeth or stumps and putting in their places some sound ones drawn immediately out 
of some poor body’s head.”31 At that time the primary objective of endodontics was to 
relieve pain and preserve the tooth. Many times these crude attempts were unsuccessful, 
and this prompted new experimentation on technique and theory. Many theories were 
established as the cause of tooth pain. Pierre Fauchard is considered “the father of 
modern dentistry” and wrote the book The Surgeon Dentist which gave descriptions of 
various dental procedures. This book gave detailed descriptions of pulp chambers and 
canal anatomy of human teeth, the procedure of relieving an abscessed tooth by accessing 
the tooth and leaving it open for a period up to two months, and then filling the pulp 
chamber with lead foil. Pulp removal was done by using a small pin to extirpate the pulp. 
Fauchard’s treatment for carious lesions involved the application of many oils left for a 
period of weeks. For persistent tooth pain that could not be addressed by his described 
methods, he mixed opium with the oils he used.
31,32
 
In the 18
th
 century, several ideas and concepts were introduced to preserve the 
pulp. An important attempt was made by Phillip Pfaff, a German dentist. He was the first 
to describe a pulp capping procedure. He cut a piece of metal (gold or lead) to fit over the 
exposed pulp.
31
  Thomas Roders described the pulp capping procedure in more detail by 
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presenting 220 cases of pulp capping where 202 were considered to be successful. His 
criteria for success included: good patient health, no inflammatory tendencies related to 
the patient, no history of previous pain, and no other disease associated with the tooth in 
question.
31
 Codman objectified pulp capping as obtaining secondary dentin at the site of 
pulp exposure. He was the first to define the objective of pulp capping as secondary 
dentin deposition.
33
 However, a few years later G.V. Black reviewed 42 cases of pulp 
capping with a 10 year follow-up and concluded that only six were considered successful 
at five years.
32
 
The 19
th 
century brought advances in canal treatments in endodontics. Formalin 
was  discovered and used to fix the pulp tissue.
30
 John P. Buckley first introduced 
formocresol to the dental profession. It was made from a mixture of tricresol and 
formalin, although it would eventually be questioned due to the potential for toxicity. 
Formocresol was used for more than 50 years.
34-36
 Also In the 19
th
 century, the first 
instrument was made consisting of a watch spring and the concept of filing the canal; the 
rubber dam was introduced to dentistry  and consisted of a thin sheet of rubber to isolate 
the tooth during gold foil restorations.
31, 37
 Clarke Dubuqe introduced gutta-percha as an 
obturation material.
31
 The technique consisted of placing hot gutta-percha into the root 
and delivering it to the apex with a hot churning instrument.
31,33
 Another significant 
finding was by Rodgers who published an article in Dental Cosmos and suggested that 
pathogenic organisms may be the etiology of the diseased pulp.
38
  Rodgers advocated that 
successful endodontic treatment was a direct result of pathogenic organism destruction. 
With the recent theory of pathogenic organisms in diseased pulps, Charles S. Tomes 
attributed this contamination to the lack of tooth vitality.
38
  Toward the end of the 19
th
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century, W.D. Miller created the bacteriological basis for endodontic treatment and 
published it in a paper that discussed gangrenous tooth pulps as centers of infection.
38
  
This new concept justified pulp therapy and dentists began using toxic materials (phenol, 
tricresol-formol, paraformaldehyde, camphor, etc.) to kill bacteria. Eventually, many of 
these toxic materials would be evaluated and discontinued. 
The 20
th
 century brought significant advancements. One of the major ones in the 
development of endodontics was the discovery of x-rays by  Konrad Wilhelm von 
Roentgen  and a German dentist Otto Walkhoff.
30,31
 This new technology would not be 
accepted by the American dental profession until 1910, but once accepted, it was a 
valuable diagnostic tool on a large scale. The first dental x-ray machine was available for 
use in 1913; it was a crude first edition and would later be improved in 1919 by the 
addition of the Coolidge tube, which improved concentrating the beam.
38,39
  Edmund 
Kells transitioned the new ‘x-ray’ technology into practice with dentistry forever 
changing the profession.
40
 Shortly thereafter, periapical radiolucencies were visualized 
and radiography became a part of diagnosing pulpless teeth.
40
 In the early 1900s, 
techniques were introduced for root length measurement and obturation level so 
overfilling could be prevented.
34
 This period was a critical time for advancement in 
endodontics; radiographs and safe local anesthetics were available, and this set the stage 
for rapid progress in all areas of endodontics.
41
 
Endodontics had a setback when William Hunter, an English physician and 
pathologist, gave a lecture on focal infection, and for more than 20 years it blocked 
research and the teaching of endodontics.
30
 His lecture, “The Role of Sepsis and 
Antisepsis in Medicine,” theorized many physical ailments were a result of dental 
11 
 
treatment.
42
 For the next 25 years no attempts were made to save devitalized teeth by 
most dentists. Teeth were extracted due to adherence to the focal infection theory. 
Nevertheless, there was a group of men who continued to improve their current 
procedures and administer treatment. These men included Coolidge, Grove, Prinz, 
Callahan, Reihn, and Johnson. Thanks to their efforts the principles of endodontics 
persisted. By the late 1940s the focal infection theory was debunked and endodontic 
treatment began to regain acceptance.
42
 
In the 1920s Hermann used a calcium hydroxide paste for filling root canals and 
later in the 1930s he supported the use of calcium hydroxide for pulp capping, 
pulpotomy, pulpectomy, and for medication of infected canals.
38,43
 His advocacy for 
calcium hydroxide came from the previous use of caustic medicaments. He deduced that 
these toxic materials would find their way into the surrounding dental tissues. He also 
demonstrated calcium hydroxide’s effectiveness by severing a viable pulp and in 
response to calcium hydroxide a dentinal bridge was formed over the severed pulp.
38
 
The 20
th
 century brought many innovations and scientific reasoning to 
endodontics. The first obturation cement was suggested for use by U. G. Rickert.
44
 He 
coated a gutta-percha cone with cement then placed the cone in the canal with pressure.
44
  
Shortly after this innovation, an instrument was designed to laterally condense the gutta-
percha improving the lateral and apical distribution of the obturation material.
34
 The same 
year Rickert introduced his root canal cement, and a Lentulo demonstrated his rotary 
paste inserter. It was a spiral wire made of flexible steel, when rotated counterclockwise, 
it carried medicaments to the apical area of the canal.
44
 It was soon accepted and 
recommended for the delivery of Rickert’s root canal cement.44 
12 
 
In the 1940s Adams and Grossman introduced antibiotic use in root canal therapy 
and were the first to use penicillin in pulp canal therapy.
34
  Grossman recommended a 
non-aqueous preparation of penicillin for intracanal use. He hypothesized that it would be 
more stable than the aqueous form. He later used impregnated paper points in the canal to 
sterilize the canal space.
44,45
  Intracanal antibiotic therapy was logical and promising at 
the time and created a shift in the management of periapical disease.
44
 There was an 
increased focus on chemotherapeutic treatment and less emphasis on the mechanical 
cleaning and shaping.
44,46
  However, resistant strains of microorganisms eventually 
surfaced, requiring the use of additional antibiotics.
44
 Science and technology produced a 
variety of antibiotics, but it was later discovered that antibiotic therapy did not 
completely sterilize the root canal space. In the early 1950s, there was a shift back to 
emphasizing the importance of mechanical cleaning of the root canal system and not 
relying solely on drug therapy. This introduced the concept of chemo-mechanical 
cleaning of the canal system to reduce bacteria and obtain asepsis.
44,46
  These important 
changes with science and drug therapy laid the foundation for the goals of endodontics. 
 In 1943, 20 dentists convened with the intention to form an organization of 
endodontists.
47
 Their organization continued to grow and in 1956 the American Board of 
Endodontics was created. The American Dental Association recognized endodontics as a 
specialty in 1963.
47
  
THEORY OF ENDODONTICS  
 In 1965 Kakehashi, Stanley, and Fitzgerald showed that pulpal and endodontic 
problems are caused primarily by bacterial contamination.
48
 The  objective of endodontic 
therapy is the same for both primary and secondary infections; it is to eliminate microbial 
13 
 
insult to the pulpal and periapical tissues to maintain natural form, function, and 
esthetics.
49,50
 Periradicular periodontitis is defined as inflammation and destruction of the 
periodontium that may or may not produce symptoms.
51
 Bacterial byproducts that are 
found within the canal space can exit through the apex and lateral, or accessory canals 
that can produce periradicular inflammation.
52
 Endodontic success is directly correlated 
with the reduction of bacteria in the canal space.
48,53
 Bacterial reduction is achieved by 
cleaning and shaping of the canal system.
49,50,54
 Modern endodontic practice is concerned 
with first opening the canals so that a reservoir exists to facilitate irrigation solution 
introduction into the canals for effective disinfection.
55,56
 In his 1955 study, G.G. Stewart 
described three phases of root canal therapy: chemomechanical preparation, microbial 
control, and obturation of the root canal.
57
 His study concluded that chemomechanical 
preparation was the most important part of endodontic treatment. As canal diameter is 
increased during mechanical preparation, the dentinal walls are cleaned by direct contact 
and debris and bacteria are removed. This enlargement also promotes irrigation solution 
delivery to the apical area. Grossman
58
 later confirmed Stewart’s findings that 
chemomechanical instrumentation is effective at removing bacteria and debris. In 
addition Grossman provided 13 principles that should be followed during root canal 
therapy: 
1. Aseptic technique. 
2. Instruments should remain within the root canal. 
3. Instruments should never be forced apically. 
4. Canal space must be enlarged from its original size. 
5. Root canal system should be continuously irrigated with an antiseptic. 
14 
 
6. Solutions should remain within the canal space. 
7. Fistulas do not require special treatment. 
8. A negative culture should be obtained before obturation of the root canal. 
9. A hermetic seal of the root canal system should be obtained. 
10.  Obturation material should not be irrigating to the periapical tissues. 
11.  If an acute alveolar abscess is present, proper drainage must be established. 
12.  Injections into infectious areas should be avoided. 
13. Apical surgery may be required to promote healing of the pulpless tooth. 
As Schilder
59
 stated in 1967, the ultimate objective of endodontic therapy is the 
removal of diseased tissue and contents to reduce infection and inflammation of the 
periapical tissues. Schilder recommended chemomechanical preparation of the canal with 
instruments and antiseptics followed by a three-dimensional obturation to the 
cementodentinal junction or 0.5 mm to 1 mm from the radiographic apex.  Pitt Ford
60
 
subsequently expanded on Schilder’s objectives for obturation and gave three reasons for 
the importance of three dimensional obturation: First, obturation of the canal space would 
leave less space for bacterial colonization. Second, it prevents apical contamination and 
third, it prevents bacterial movement along the canal walls. Weine
61
 argued that to 
achieve the objective of endodontics, it is necessary to completely debride the canal of 
bacteria and debris. Furthermore, he stated that when canals are properly cleaned and 
shaped, any method of obturation is adequate; rubber dams are mandatory to prevent 
contamination; all endodontically treated teeth need adequate restorations; and patients 
should be evaluated for healing. All these factors contribute to a successful outcome in 
root canal therapy. 
15 
 
MICROORGANISMS  
 A primary intraradicular infection is an infection of the necrotic pulp space and is 
the etiologic agent of apical periodontitis.
62
 It is a mixed community of mainly anaerobic 
gram-negative and gram-positive bacteria.  The gram-negative bacteria are frequently 
identified as Fusobacterium, Dialister, Porphyromonas, Prevotella, Tannerella, 
Treponema, Campylobacter and Veillonella. Gram-positive bacteria are identified as: 
Parvimonas, Fillifactor, Pseudoramibacter, Olsenella, Actinomyces, Peptostreptococcus, 
Streptococcus, Propionibacterium and Eubacterium.
63
 Morphological studies have 
shown that the bacteria found in primary infections are diverse and includes cocci, rods, 
filaments and spirilla.
64,65
 It is well-known that bacteria that colonize the root canal grow 
mainly in sessile biofilm communities adhering to the dentinal walls.
65
 This gives 
bacteria uninhibited access to dentinal tubules and dentinal tubule infection reportedly 
occurs in 70 percent to 80 percent of teeth with apical periodontitis.
66
 
Root canal infection is characterized by a change in bacterial species during 
different stages of the infection.
62
  These changes in bacterial diversity are a result of 
changes in the environmental conditions especially with changes in oxygen and nutrient 
availability.
67
 The initial infection involves mainly facultative bacteria, and after a few 
days or weeks, oxygen becomes limited due to metabolism of initial bacteria and reduced 
blood flow due to pulp necrosis. This creates an environment suitable for the anaerobic 
bacteria and they begin to dominate.
62 
Porphyromonas gingivalis is an asaccharolytic, non-motile, obligatory anaerobic, 
coccobacilli gram-negative rod.
68
 It can be found primarily in subgingival plaque and can 
also be found on the tonsils and dorsum of tongue.
69
 P. gingivalis has been shown to 
16 
 
occur in endodontic infections with chronic apical periodontitis, acute apical 
periodontitis, and acute apical abscesses.
41
 The reported incidence of P. gingivalis ranges 
among the literature from 5 percent to 97 percent.
22,24
 Clonal types of P. gingivalis can 
have varying degrees of virulence, and there is a high degree of heterogeneity reported 
for P. gingivalis. Different strains have been shown to differ in their tissue destruction.
22
 
Siqueira et al.
22
 confirmed the findings of many other studies in that P. gingivalis is one 
of the most pathogenic species present in the human oral cavity. P. gingivalis produces 
many enzymes, proteins, and metabolic end products that are active against a wide range 
of host proteins and provides routes for evading host defenses.
68
 The most common 
virulence factors of P. gingivalis are lipopolysaccharide, fimbriae, capsule, lipoproteins, 
outer membrane proteins, proteinases (collagenase, gingipains), fibrinolysin, 
phospholipase, alkaline and acid phosphatases, nucleases, hyaluronidase, chondroitin 
sulfatase, hemolysins, and toxic metabolites.
68,69
 These virulence factors give P. 
gingivalis many mechanisms for self-preservation and disease pathogenesis to the host. 
Siqueira et al.
69
 states that these virulence factors can further the disease process by 
acting as adhesins to promote bacterial aggregation to form biofilms; sustenins to 
maintain growth and survival; invasins to allow invasion of tissue; evasins to evade host 
defenses; aggressins to cause direct tissue damage; and modulins for indirect tissue 
damage. It is clear that the pathogenicity of P. gingivalis is diverse and not limited to a 
few virulence factors. These mechanisms for pathogenesis give insight to how P. 
gingivalis is able to invade root canal systems and cause infection. 
A secondary infection results when bacteria that were not present in the primary 
infection are subsequently introduced into the root canal after root canal therapy.
70
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Bacteria responsible for secondary infections can gain access to the canal space during 
treatment, between appointments, or even after obturation via coronal leakage.
62,71
 
Whatever the avenue, it is most likely traced back to an oversight in asepsis.
62
 The 
bacterial diversity of secondary infections is lower than for primary; the presence of 
Pseudomonas aeruginosa, staphylococcus species, Escherichia coli, and Enterococcus 
faecalis are characteristic of a secondary infection.
62
 Gram-negative bacteria that are 
commonly involved in primary infections are usually eliminated.
72
 Many studies have 
shown that E. faecalis is the most frequently found bacteria in secondarily infected 
canals.
73,74 Its persistence in canals is attributed to its ability to colonize the canal space 
and resist treatment procedures.
75
 In general, most studies show that when bacteria 
persist, gram-positive bacteria are more frequent.  
 
REGENERATIVE PROCEDURES  
Regeneration of tissue back to its original and functional state has always been a 
goal for medicine.
76
 Regenerative medicine is centered on three key components: stem 
cells, scaffolds, and growth factors to replace diseased or damaged tissues and restore 
physiological function. One of the key components of regenerative medicine is the use of 
a scaffold. The scaffold provides a three-dimensional environment for cells to attach and 
grow mimicking the extracellular matrix of the in vivo tissue.
76
  A new biomedical field 
aimed at developing this approach is called tissue engineering. The goals of tissue 
engineering are regeneration of natural tissues and the creation of biological substitutes 
for defective, lost, or diseased tissue by utilizing stem cells, growth factors and 
scaffolds.
1,77,78
  
18 
 
With the recent advances in tissue engineering in medicine, there has been 
considerable effort in clinical studies and research towards regeneration of the pulp 
dentin complex in endodontics.
79
 Dentistry is the practice of replacing lost or diseased 
tooth structure with a functional substitute of inert materials.
41
 Regenerative efforts focus 
on the biologic replacement of diseased or damaged tissues. Early attempts of 
regenerating dental tissues began in the 1950s by B.W. Herman
80
 when he described 
calcium hydroxide application for vital pulp therapy. Ostby
81
 later  attempted to 
determine if filling the canal with a blood clot would lead to regeneration. In the 1970s, 
Myers et al.
82
 conducted similar experiments with generation of soft tissue observed, but 
only 0.1-1.0 mm of ingrowth was seen.  The reason for poor results is that pulp tissue is 
different from periapical tissue. Therefore, pulpal regeneration from cells in adjacent 
tissue is unlikely.
76
 Over the past several years, significant advancements have been made 
in dentistry with regenerative procedures; guided tissue and bone regeneration are areas 
that have seen significant improvements. 
 
Stem Cells 
All biological tissues have stem cell origin.
83
 A stem cell is defined as a cell that 
can continuously divide and produce cells that can develop into many other types of cells 
and consequently different tissues.
4
 Fortier
84
 describes stem cells as embryonic (fetal) or 
adult (postnatal). These cells have different plasticities (potential for developing into 
specialized cells).
85
 Stem cells can be further classified as totipotent, pluripotent, and 
multipotent with varying degrees of plasticity and source.
4
 It is well known that 
embryonic stem cells have more plasticity than postnatal cells.
86
 The more plasticity a 
cell has, the more potential for use in tissue engineering.
87
 Although postnatal stem cells 
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have less plasticity, researchers have shown an increased interest due to ethical and legal 
issues.
4
 Postnatal stem cells can be harvested from the umbilical cord, bone marrow, 
peripheral body fat, and many other tissues including the dental pulp.
4, 88
 Dental pulp 
stem cells (DPSCs) are postnatal, multipotent stem cells.
12
 Postnatal DPSCs are the most 
promising for endodontic tissue regeneration.
89
 Stem cells can be further categorized by 
their source. Autologous cells come from the same person in whom the cells will be used.  
Some examples include bone marrow, adipose cells, the periodontal ligament, and 
umbilical cord to name a few.  Allogeneic cells come from a donor of the same species. 
Some examples include blood transfusion and bone marrow transplants where the donor 
is not the same person as the recipient. Xenogeneic cells are cells from another species. 
An example would be animal cells that have been used in cardiovascular implants.
90
 The 
dental pulp is known to have regenerative capabilities.
91,92
 The pulp cells have the 
potential to differentiate into odontoblasts after carious exposure by responding to growth 
factors released from the surrounding dentin.
11
 In the dental pulp, stem cells can be found 
concentrated in the perivascular region and the cell-rich zone next to the odontoblastic 
layer.
41
  The pulp consists of fibroblasts, extracellular matrix, and collagen. To form this 
complex organization of loose connective tissue, several cell types are needed. Gronthos 
et al.
89
  reported that at least five different types of postnatal mesenchymal stem cells 
have been identified in the formation of the dentin-pulp complex: 1) dental pulp stem 
cells (DPSC), 2) stem cells of human exfoliated deciduous teeth (SHED), 3) stem cells of 
the apical papilla (SCAP),  4) dental follicle progenitor cells (DFPC), 5) bone marrow 
derived mesenchymal stem cells (BMMSC). It has been found that the younger the 
patient is, the better the chance of having autologous stem cells available.
4
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Growth Factors 
According to Smith,
92
 growth factors are peptide molecules that transmit signals 
between cells functioning as stimulators or inhibitors of growth as well as modulators of 
cell differentiation. Growth factors can be classified based on their actions on cells. 
Autocrine growth factors act on the same cell where it was produced; juxtacrine growth 
factors act on neighboring cells, and paracrine growth factors act on cells in distant 
tissue.
77
 These molecules are essential for cell activity and signal changes in tooth 
morphogenesis and differentiation by interacting with specific receptors on cells which 
causes a cascade of intracellular changes.
77,92
 While there is much understanding of 
cytokines and growth factors involved with inflammation and immune responses, growth 
factors and signaling molecules related to pulpal repair and regeneration have only 
recently been identified.
92
 The current understanding and role of identified growth factors 
is incomplete and a growing question in research. Regenerative endodontics relies on the 
release and use of growth factors to induce regeneration of tissue into the canal space.  
Recently, several growth factors have been identified and studied in relation to pulpal 
regeneration, transforming growth factor beta (TGF-B), bone morphogenic protein 
(BMP), and vascular endothelial growth factor (VEGF). TGF-B signals odontoblast 
differentiation, mineralization of pulp tissue, anti-inflammatory effects, and promotes 
wound healing.
4, 92
 TGF has an overall effect of stimulating dentin matrix production, 
which is critical for root length and width development. TGF is found in the dentin 
matrix because it is secreted by odontoblasts in the matrix. BMP is another important 
growth factor in the regeneration procedure. BMP induces differentiation of odontoblasts, 
which results in mineralization of deposited bone critical to continued root 
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development.
4,92
 VGEF is another important growth factor involved in the regenerative 
process; in wound healing vascularity is a critical factor for success. VGEF regulates 
angiogenesis by inducing chemotaxis, proliferation, and differentiation of cells for 
vascular ingrowth and dental pulp cells.
4,92
 Other reports showing growth factors 
embedded in dentin are released during dentin demineralization with EDTA.
9,92
 Dentin 
inherently has many growth factors associated with it. Demineralization of dentin can 
expose dentinal tubules; with this dissolution of tissue growth factors are released into the 
environment of the canal space.
4
 The effectiveness of this source of growth factors is 
unclear, but studies show EDTA to very effective at releasing these growth factors.
9
 Once 
these growth factors are released, they are capable of signaling the repair and 
regeneration of the pulp dentin complex.
93
  While it is known that growth factors have a 
positive effect on successful regeneration, a complete knowledge of all growth factors 
involved and their distribution and concentrations is still unknown. 
 
Scaffolds 
Tissue engineering is a multidisciplinary field which has the potential to produce 
an artificial, functional, and immunologically tolerant organ tissue that grows in the 
patient.
78
 This technology could give a permanent solution to a diseased or damaged 
organ. A critical component of tissue engineering involves a three dimensional substrate 
for the ingrowth of cells.
4,11,14,17,78, 90,94,95
 These three-dimensional substrates are known 
as scaffolds. Scaffolds provide an environment for cell growth, differentiation, and 
angiogenesis to allow for integration with the host tissue.
96
 Scaffolds function to provide 
a spatially correct positioning of the cell for appropriate growth conditions similar to the 
extracellular matrix.
4,11,97
 Hutmacher
98
 outlined the properties of a scaffold for tissue 
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engineering. First, the scaffold should be porous for tissue and vascular integration. 
Second, it must be biodegradable at a rate of tissue formation. Third, the scaffold must 
allow cellular attachment for differentiation and proliferation. Fourth, the mechanical 
properties of the site being implanted must be adequate. Fifth, the scaffold should not 
elicit any adverse reactions. Finally, it should be easily shaped into different sizes and 
shapes. Potential materials with these characteristic are natural polymers, synthetic 
polymers, ceramics, and combinations of these materials.
99
  
Scaffolds can be categorized as either natural or synthetic. Examples of natural 
scaffolds include collagen, glycosaminoglycans, demineralized or native dentin matrix, 
and platelet rich plasma or (PRP).
41
 When implanted, natural scaffolds start a host-tissue 
response that initiates the necessary biological responses to restore structure and function 
of the tissue being grafted.
96
 Naturally occurring scaffolds also prevent many of the 
complications with foreign body reactions and are more readily recognized by the body.
96
 
The pulp space represents a significantly different environment for tissue engineering. 
Natural scaffolds present some challenges. Collagen gel has mainly been used as a 
scaffold material for the canal space. Collagen presents some shortcomings;  it has shown 
severe contraction after placement resulting in undesirable mechanical properties, lack of 
dentin attachment, unstable healing, and insufficient regeneration of dentin-like 
tissue.
76,100
 Other studies have shown success when using collagen as a scaffold 
material.
101
  Its success in the literature is controversial. In the current pulpal regeneration 
procedure, a natural scaffold is used, which is a blood clot. The blood clot has limitations 
that need to be overcome for future progress of this exciting new treatment. A critical 
limitation to the blood clot revascularization approach is that the concentration and 
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composition of cells trapped in the fibrin clot are unpredictable.
4
 Therefore, there could 
be variation in treatment outcome; the use of effective concentrations and compositions 
of cells is critical to success.
4
  
Synthetic scaffold examples include polylactic acid (PLA), polyglycolic acid 
(PGA), polylactic-coglycolic acid (PLGA), hydroxyapatite, and bioceramics.
41
 Polymer 
has been used in medicine since the discovery of polymers.
77
 Nylon sutures were 
introduced in the 1940s and by the mid-1940s, they were significantly represented in the 
medical literature.
77
 Since then, polymer use has expanded to prosthetics, grafts, 
implants, and artificial lenses. Polymer in-vivo use has been well-documented and 
accepted in medicine.
77
 Currently, polymers are being applied in the field of tissue 
engineering and used to assist in the regeneration of three-dimensional structures.
1,77,78 
Research has shown significant promise with synthetic polymer scaffolds and their 
clinical use and may have the most promise for creating replacement tissue.
2,18,102,103
 
Human dental pulp cells and fibroblasts have been shown to successfully adhere, 
proliferate, and produce extracellular matrix when seeded on polymer scaffolds in 
vitro.
3,7,14 Polymer scaffolds have many desirable properties for tissue engineering. When 
the polymer diameter is reduced to nanometers, the surface area increases dramatically 
and still remains functional with excellent mechanical and degradation properties.
104
 
Once in place, tissue formation relies on mechanical properties of the scaffold for cell 
growth and transmits them appropriately to surrounding tissue.
105
 Degradation is essential 
for functional tissue regeneration and, ideally, the rate of degradation should mirror the 
rate of new tissue formation.
18,19,105
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Scaffold Fabrication Methods 
Electrospinning has gained attention because of the ability to manipulate many 
polymers and also for creating fibers with crucial properties for scaffold use. 
Electrospinning can increase fiber surface area, create ideal surface morphologies, and 
has excellent mechanical properties.
106
  Thus, scaffolds used for tissue engineering have 
been researched in the electrospinning field.
106-108
  Non-woven electrospun nanofibers are 
very similar to the fibers in the extracellular matrix (ECM), which is advantageous for 
cell migration, distribution of necessary nutrients, and architecture.
106
 Electrospun 
nanofibers are now an important part in vascular, neural, and tendinous tissue 
engineering.
106
  
Polydioxanone (PDS) is a colorless, bioabsorbable, monofilament polymer that 
was made specifically for sutures. The PDS used for electrospinning in this study was 
obtained from Ethicon, Inc. (Somerville, NJ). As a suture, it has high flexibility 
independent of filament diameter, excellent shape memory, high strength, slow 
absorption rates, and low inflammatory response when compared with Vicryl and 
Dexon.
109
 Upon degradation, 50 percent of its strength is reduced after three weeks, and 
by six months it is completely absorbed.
109
  Electrospinning forms pores that are crucial 
for diffusion of molecules, cell integration and migration into the scaffold.
109
  With these 
desirable properties, it has promise for tissue engineering uses.  
There has been increasing interest in the incorporation of drugs into electrospun 
fibers.
106
 An ideal scaffold should also maintain an antimicrobial environment to reduce 
contamination and promote healing.
19
 Many drugs can be incorporated into electrospun 
polymers through electrospinning.
106
 Local delivery of drugs by electrospun scaffolds 
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could significantly reduce systemic involvement of the drug while still delivering local 
effects.
106
  The morphological features of electrospun polymers allow for potential and  
efficient drug release.  Currently, these polymeric nanofibers are under investigation for 
application in drug use.
106,110,111
 The electrospinning technique allows the molecular 
structure and bioactivity to remain intact
106
 and drug release can be manipulated to be 
rapid, immediate, or delayed.
106,112
  In the case of regenerative endodontics, an antibiotic 
dressing is applied and changed if needed.
4,14,113-116
 Reapplication or changing of 
antibiotic dressings is an inconvenient process and increases risk of contamination. In the 
endodontic revitalization procedure the TAP must be removed and sometimes changed. 
Eliminating this step could improve treatment outcomes. 
  In this study, metronidazole was chosen because of its efficacy against obligate 
anaerobes, which are known endodontic pathogens.
22,24,113,117-119
 In the present study, a 
5.0- wt % MET and 25-wt % MET mixture were electrospun into two different scaffolds. 
Studies have shown that therapeutic doses of antibiotics have been successfully delivered 
with polymer scaffolds.
18,19,21
 This has not been attempted in an endodontic application. 
Regenerative Endodontics 
Regenerative endodontics is defined as a biologically-based procedure designed 
to replace damaged, diseased, or missing dentin and root structures, as well as cells that 
restore the normal physiological functions of the pulp dentin complex.
4,14
 Hemorrhage 
into a surgical or wound site resulting in a blood clot has been the foundation of creating 
an environment for healing. Ostby tested this principle in endodontics in the 1950s to 
investigate pulpal regeneration.
81
 In the 1970s, Myers conducted similar experiments and 
was successful in soft tissue formation. However, it was limited to very small distances 
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into the canal and, furthermore, connective tissue ingrowth was not enhanced by blood or 
blood substitutes.
82
  Histological findings have shown that with complete loss or 
degeneration of pulp tissue, the canal space is invaded by periapical tissue.
120,121
 In the 
1990s pulp-tissue regeneration was revisited with modern tissue engineering technology 
advancements.
76
 Later in-vitro reports showed pulp cells were capable of induction to 
become odontoblast-like cells and deposit dentin like hard tissue.
88,122
 Gronthos et al.
89
 
reported  in vivo evidence of pulp cells depositing dentin in mice.
123
 This and other 
research introduced the possibility of applying this technology clinically. Murray et al.
4
 
listed several regenerative endodontic techniques: (a) root canal revascularization via 
blood clotting; (b) postnatal stem cell therapy; (c) pulp implantation; (d) scaffold 
implantation; (e) injectable scaffold; (f) three-dimensional cell printing and; (g) gene 
delivery.
4
 These procedures are based on tissue engineering principles that include cells, 
growth factors, and scaffolds. In the past, clinically acceptable results have been obtained 
through apexification procedures using long-term calcium hydroxide treatment. However, 
calcium hydroxide may negatively affect dentin with long-term use.
9
 When presented 
with a necrotic immature tooth, endodontic therapy cannot prevent susceptibility to 
fracture in the future.
124,125
 The advantage of regenerative endodontics over apexification 
is that continued root maturation is seen along with the ingrowth of vital tissue.
126
 As 
regenerative endodontic procedures improve, they may become the standard of care, 
replacing previous techniques; and with improved knowledge and techniques, they may 
be applied to mature teeth in the future.
9,127
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Clinical Regenerative Endodontic Procedures 
 
 
Apexogenesis 
Apexogenesis is aimed at maintaining vital pulp tissue in the canal system to 
sustain continued root formation.
41
 Unlike apexification, apexogenesis allows the root to 
continue normal development resulting in increased thickness and length of root 
structure. In the first 24 hours, the inflammation is located superficially in the pulp and 
after that, it moves more apically.
128
 Clinically, a large or deep pulpotomy is done to 
remove inflamed and infected pulp tissue, allowing healthy tissue to remain in the canal. 
Apexogenesis can be accomplished in single-rooted anterior or posterior multirooted 
teeth. The tooth is accessed; a deep pulpotomy and hemostasis are completed, and the 
remaining pulp is treated with a dressing on the coronal aspect. In most cases, this 
dressing is some form of calcium hydroxide. Calcium hydroxide has been the dressing of 
choice for many years; however, it has some disadvantages. Studies have shown it can be 
unpredictable and also incorporates irregularities to the developing reparative dentin, 
which can be an avenue for bacterial contamination.
129
 An alternative capping material is 
mineral trioxide aggregate (MTA). MTA has been shown to induce hard tissue formation 
in pulp tissues.
128
 Studies have shown that MTA has the ability to induce a thicker 
dentinal bridge, less pulpal necrosis, and less pulpal inflammation.
128,129
  However, MTA 
comes with some disadvantages; namely, it is more costly and has a delayed setting time.  
After successful dressing placement, the coronal access is sealed with a restoration. The 
patient is recalled, and the root is monitored for continued root development and dentin 
bridge formation beneath the dressing material. Apexogenesis is indicated when a tooth is 
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vital, or the apex is not completely formed, or there is a desire to maintain the tooth. With 
improved dressing materials, apexogenesis has become a more predictable procedure. 
Apexification 
Apexification is a procedure to form a calcified barrier at the apex of a nonvital 
permanent tooth; this barrier serves as a matrix that obturation material can be condensed 
against. Clinically, the canal is accessed and disinfected with minimal instrumentation to 
avoid weakening the thin dentinal walls; working length is determined radiographically. 
After debridement, calcium hydroxide is placed into the canal and access is sealed. The 
patient is then recalled at three-month intervals to determine apical barrier formation. 
After adequate barrier formation, the canal is obturated and a permanent restoration is 
placed in the access. The most important steps of the procedure are effective debridement 
of the canal and sealing the access. Apexification is not an attempt to reintroduce vital 
tissue into the canal space and has disadvantages. The long-term use of calcium 
hydroxide can reduce root strength.
130,131
 In a large case series using apexification, the  
chief reason for tooth loss was root fracture.
41
 Apexification is only capable of root end 
closure; no additional root structure is increased by length or thickness. It is considered 
the treatment of last resort. 
Revascularization 
 
The necrotic immature tooth presents potential complications for treatment. 
Standard cleaning and shaping with endodontic files are troublesome due to the thin 
dentinal walls. This is because instrumentation would further weaken the tooth.
126
 
Obturation is difficult as the apical seal is unpredictable due to the large immature apex.
41
 
Apexification has historically shown success; however, the long-term prognosis has not 
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been well-documented.
126,132,133
 Even if an apical barrier is successfully formed, there is 
an increased risk of fracture. It has been shown that up to 30 percent of immature teeth 
can fracture after treatment.
133
 Composite resin has been used to clinically strengthen the 
roots of immature necrotic teeth. This has internally increased the strength, but it 
eliminates the option for retreatment.
134
 This would imply an ideal solution to the 
immature necrotic tooth would be to regenerate mineralized tooth structure. The goal of 
the revascularization procedure is to replace the damaged or diseased pulp tissue in the 
canal space.
4,41
 Choen et al.
41
 describe the clinical procedure as follows: during the first 
appointment, the tooth is isolated and accessed; working length is determined and 
irrigated with 20 ml of NaOCl; the canal is then dried with paper points and a triple 
antibiotic paste is placed in canal space. Bacteria present in the necrotic canal and deep 
layers of canal walls have been reported to be predominately obligate anaerobes.
118
 
Metronidazole has a wide spectrum of bactericidal action against oral obligate anaerobes, 
even in the necrotic pulp.
118,119,135
 Hoshino et al.
113
 found that 99 percent of bacteria in 
carious lesions and infected root dentin were eradicated in the presence of metronidazole. 
However, metronidazole did not kill all the bacteria, which suggests more antibiotics may 
be needed. Sato et al.
119
 reported that ciprofloxacin, metronidazole, and minocycline can 
sterilize root dentin. In a later study, Sato et al.,
118
 using the same triad of antibiotics, 
found that, in vitro, no bacteria were recovered in test tooth samples after 48 hours. They 
also found that triple antibiotic paste was able to penetrate 1 mm into dentin after 48 
hours and was therefore an effective medicament for sterilization of the root canal. After 
antibiotic placement, the tooth is then sealed with a sterile sponge and a temporary 
restorative material. After 3 weeks to 4 weeks, the patient returns for the second 
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appointment. At this appointment, the tooth is isolated and re-accessed. Again, the canal 
is irrigated with 20 ml of NaOCl to remove the antibacterial paste, and according to 
Hargreaves,
9
 a 10-ml rinse with EDTA is used to partially demineralize dentin and 
release embedded growth factors in dentin. Yamauchi et al.
126
 suggested that partial 
dentin demineralization could help the adherence of mineralized tissue to the inner dentin 
walls. The canal is then dried with paper points; a large K file is placed a few millimeters 
beyond the apical foramen, and the apical tissue is lacerated. Bleeding was induced into 
the canal up to 3 mm from the CEJ. This blood clot serves as a scaffold for the 
regeneration of pulpal tissue. It has been shown that in humans, inducing bleeding into 
the canal space after disinfection can promote mineralized tooth structure thickening and 
lengthening.
136
 Thibodeau et al.
137
 concluded in a recent study that although the blood 
clot was not quantified, it was useful to induce tissue formation in the previously necrotic 
canal space. Murray et al.
4
 have shown the blood clot contains vital components for 
regenerative endodontics. He also states these components are unpredictable and 
incomplete. Platelets are a major component of the blood clot. They secrete growth 
factors and have necessary serum proteins including fibrin, fibronectin, and cell adhesion 
molecules for osteoconduction.
126
 Platelets are also known to function as a matrix for 
bone, connective tissue, and epithelial cell migration in wound healing.
138
  It is accepted 
that the blood clot serves as a natural scaffold for stem cell migration and new tissue 
formation in the canal space.
139
 After successful bleeding into the canal space, a piece of 
Colla-Plug is then placed on top of the bleeding to serve as a matrix to condense MTA. 
About 3 mm to 4 mm of MTA is placed and the access is sealed with a restoration. As 
apical development continues, Yamauchi et al.
126
 found two types of hard tissue 
31 
 
deposition after histological study. The first was called dentin-associated mineralized 
tissue (DAMT), which they describe as “mineralized tissue with relatively uniform 
thickness devoid of vasculature, and some portion is anchored to the dentin wall and 
some detached.”126 The second was called bony islands (BI) located in the inner lumen 
and independent of the dentin wall. They reported that BI was distinct from DAMT and 
BI “appeared as mineralized matrix islands that contained many embedded cells, blood 
vessels, and bone marrow-like tissues.”126 Yamauchi et al.126 also concluded that the use 
of a scaffold was necessary to increase mineralized tissue formation. 
In regenerative endodontics scaffolds, stem cells, and growth factors are essential 
for regeneration. However, there first needs to be an aseptic environment to facilitate the 
function of the three components. Irrigation solutions place a critical role in this area. 
 
IRRIGATION  
 Canal irrigation is an essential step in non-surgical root canal therapy. It is 
responsible for the debridement and disinfection of the root canal system.
140
 This requires 
that the irrigation solution dissolves organic tissue and that the method of delivery is able 
to reach uninstrumented canal spaces.
141
 It has been shown that 35 percent to 53 percent 
of the canal system remains uninstrumented.
142,143
 The irrigation solution will help 
remove debris from the non-instrumented anatomy, have an antibacterial action, and 
dissolve of organic debris.
141,144 Harrison
145
 outlined that irrigation solutions must have 
certain properties for endodontic effectiveness:  antimicrobial properties; dissolution of 
tissues; adjunctively debride the root canal system; biocompatibility. Irrigation solutions 
are used in the regenerative procedure and are beneficial to successful outcomes. 
Presently, there is not a set standard for an appropriate irrigation regimen and thus 
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various irrigation regimens have been reported in recent case reports of the 
revascularization procedure.
146
 The irrigation regimen is based on known bactericidal and 
bacteriostatic properties of the different irrigation solutions. An irrigation regimen for the 
regenerative procedure should be based on the antimicrobial effectiveness and the ability 
to promote stem cell survival. This is a different consideration for irrigation solution use 
than what is used in traditional non-surgical endodontic procedures. 
 
Sodium Hypochlorite   
NaOCl was effectively used for wound irrigation during World War I and was 
later implemented in endodontics by Coolidge.
41,147
 It is a potent antimicrobial agent and 
effectively dissolves organic tissue such as pulp and collagen. NaOCl is available in 
many concentrations ranging from 0.5-percent to 6.0-percent.
148
 It kills bacteria quickly 
even at low concentrations. Lower concentrations are effective on tissue that is primarily 
necrotic.
149
 Higher concentrations give both necrotic and vital tissue dissolution and 
enhanced antimicrobial effectiveness.
150
 Siqueira et al.
151
 showed that NaOCl has a 
superior effect on root canal microorganisms in comparison with sterile saline.  Vianna et 
al.
152
 conducted an experiment using gram-negative anaerobic rods isolated from primary 
apical periodontitis and showed that the bacteria were killed within fifteen seconds using 
NaOCl in varying concentrations of 0.5-percent to 5.0 percent. Conversely, Estrela et 
al.
153
 in a systematic review, concluded that NaOCl and CHX are not effective in 
completely eliminating E. faecalis when PCR and other culture techniques were used. 
Regardless of the controversy, it is still the main irrigation solution used in endodontic 
therapy today. Its tissue-dissolving properties are related to the duration of exposure, 
concentration, and temperature.
141,154
 The bactericidal rates for NaOCl are doubled for 
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every 5°-C rise in temperature.
144
 NaOCl has many of the necessary properties of a root 
canal irrigation solution and is the best one available for non-surgical endodontics.
155,156
 
In the regenerative procedure, a reduced concentration of 2.5-percent is recommended. 
Trevino et al.
146
 reported the inclusion of 6-percent NaOCl decreased cell viability when 
combined with EDTA. The cytotoxic effects of NaOCl are well known and relied upon 
for traditional non-surgical root canal therapy. In contrast with the principles of 
regenerative endodontics, stem cell viability is necessary for success.
4 
 
Chlorhexidine  
Since the 1950s, chlorhexidine (CHX) has been used for disinfection applications 
and treatment of various infections in humans and animals.
41
 More recently, in dentistry, 
CHX is used intraorally for periodontics and cariology to prevent disease processes.
157, 158
 
CHX is available in various concentrations of 0.12 percent to 2.0 percent. CHX is a broad 
spectrum antimicrobial that is effective against gram-positive and gram-negative bacteria 
and yeasts.
41
  CHX’s effectiveness comes from its ability to bind to the negatively 
charged surface of bacteria damaging the outer cell wall making the cell permeable to the 
environment.
159,160
 At low concentrations, CHX is bacteriostatic by affecting cell 
metabolism; at high concentrations it is bactericidal and acting as a detergent.
41
 In 
endodontics CHX is used as an irrigation solution based on its substantivity and extended 
antimicrobial effect, which comes from binding to hydroxyapatite.
41
 CHX has been 
shown to be effective against E. faecalis biofilms in root canal systems.
161
 Because of the 
substantivity of CHX, it can remain on dentinal walls for extended periods of time 
reducing bacterial colonization.
162
 It has been shown that 2-percent CHX is a better 
endodontic irrigation solution than 0.12 percent. CHX’s antimicrobial activity is directly 
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related to the concentration.
163
 Unlike NaOCl, CHX does not possess tissue-dissolving 
properties that are essential to endodontic treatment.
41
 CHX has been advocated as a final 
rinse in the irrigation regimen due to its desirable properties, especially in endodontic 
retreatment.
164
  Chlorhexidine (0.12 percent and 2 percent) have been reported in the 
literature as irrigation solutions in the regenerative procedure due to their antibacterial 
activity; however, they have some limitations. They do not dissolve tissue like NaOCl; 
when combined with NaOCl they have been known to form parachloroanaline-like 
(PCA) precipitates; and they are cytotoxic to stem cells.
146,165
 Trevino et al.
146
 in an in-
vitro study examined different irrigation solution regimens and concluded CHX was 
detrimental to the stem cells of the apical papilla (SCAP) survival and that the irrigation 
regimen should be limited to the use of 17-percent EDTA and NaOCl. Thus, the use of 
CHX in the regenerative application is not advocated. 
 
EDTA 
Shahravan et al.
166
 conducted a systematic review and meta-analysis on the smear 
layer’s effect on sealability of canal obturation and concluded that smear layer removal 
improves the fluid-tight seal of the root canal system. Thus, smear layer removal is 
recommended. Ethylenediamine Tetra-Acetic Acid (EDTA) is used as an irrigation 
solution in endodontics because of its property to chelate and remove the mineralized part 
of the smear layer that is present on instrumented canal walls.
41
 Seventeen-percent EDTA 
is the concentration most commonly used in endodontics. This concentration (17 percent) 
can remove the smear layer in approximately one minute.
41
  The effect of EDTA is 
considered to be self-limiting, and when organic debris is present, EDTA can have 
decreased effectiveness.
167
  When combined with NaOCl, however, there is a synergistic 
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effect allowing for the removal of the entire smear layer and allowing deeper penetration 
into dentinal tubules.
168, 169
 Trevino et al.
146
 along with other authors have reported that 
EDTA promoted SCAP survival, possibly by promoting the release of dentinal growth 
factors that were imbedded into dentin during dentinogenesis.
4,126
 
 
OBTURATION 
Endodontic obturation is an essential part of clinical endodontics to prevent 
infection of the periapical tissues by sealing the canal space.
170
 Many materials have been 
advocated for obturation over the last 100 years. Most techniques use a core material and 
a sealer to achieve a fluid tight seal; the most common core material used is gutta-
percha.
41
 In 1940, Grossman
171
 identified the criteria for an ideal obturation material: 1) 
easily introduced; 2) liquid or semisolid and becomes solid; 3) capable of apical and 
lateral sealing; 4) no shrinkage; 5) resistant to moisture; 6) bacteriostatic; 7) does not 
stain tooth structures; 8) biocompatible with periapical tissues; 9) easy removal; 10) 
sterile when introduced into canal;  11) radiopaque. These principles are dependent on 
proper cleaning and shaping to have maximum effect. A recent meta-analysis of the 
literature compared the success of root canal therapy related to the obturation length from 
the apex. It found that success rates were better when obturation was short of the apex.
172
 
A recently published meta-analysis by Peng et al.
173
 found obturation with warm gutta-
percha resulted in a higher rate of overextension than obturation with cold gutta-percha, 
indicating warm gutta-percha obturation is more technique sensitive. In the case of the 
necrotic immature tooth, conventional obturation techniques are inadequate to fulfill 
Grossman’s criteria. The thin walls increase the risk of fracture, and the blunderbuss apex 
makes obtaining a hermetic seal very difficult with traditional materials.
9
 In regenerative 
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endodontics, the goal is to render the canal aseptic and regenerate the pulp-dentin 
complex to continue root maturation.
4, 9,174,175 If the procedure is successful, no obturation 
is necessary because there has been successful regeneration of vital tissue into the canal 
space; the access is simply sealed to prevent re-infection. Gillen et al.
176
 found the most 
predictable outcome of periapical healing comes with good quality endodontics and good 
quality coronal restoration.  
 
DIRECT CONTACT TEST 
Antimicrobial properties of restorative materials have
25 been evaluated in vitro 
using various methodologies. The agar diffusion test (ADT) was the standard assay used 
in most of these studies despite its known limitations. Problems associated with the ADT 
include its qualitative nature, ability to measure only soluble components, inability to 
distinguish between bacteriostatic and bactericidal effects, and difficulties in comparing a 
large number of samples with a large number of variables.
26
  Its use in endodontic 
research is no longer accepted due to the lack of any kind of standardization of the media 
and testing materials.
177
  
The direct contact test (DCT) has been described in the literature by Weiss et 
al.
178
 as a test based on the turbidimetric determination of bacterial growth in a 96-well 
microtiter plate. Bacterial growth in the microwells is monitored at 590 nm at 37°C and 
recorded every 30 minutes over a 12-hour period by a spectrophotometer. The DCT is a 
quantitative and reproducible method that simulates contact of the test organism with the 
material being tested.
179
 A temperature controlled spectrophotometer is used which 
allows for standardization of measurements for a large number of specimens, which is an 
advantage. The DCT allows monitoring of bacterial growth in all microwells and makes 
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it possible to measure the bactericidal effect of the materials. It makes it possible to 
directly calculate the exact numbers of surviving bacteria after each contact time. 
SUCCESS OF ENDODONTIC THERAPY  
The ultimate goal of endodontics is to prevent or heal the disease apical 
periodontitis.
180
 Endodontic outcomes should be defined in reference to healing and 
disease as follows:  
1. Healed: Both the clinical and radiographic presentations are normal. 
2. Healing: Reducing radiolucency with reduction in clinical symptoms. 
3. Disease: Radiolucency has formed or remained with no change in size. 
clinical signs or symptoms are present, even if the radiographic presentation is normal. 
4. Functional retention: The clinical presentation is normal, while 
radiolucency may be absent or present.
181
 
Healing of endodontically treated teeth has been addressed in many studies, but 
even comprehensive review of those studies show inconsistencies and  outcome 
variability.
182,183
 Because of the variability in the data included in these studies, the 
outcomes can be misleading. Clinical studies provide varying levels of evidence and  
must be compared against a well-defined criteria to differentiate them according to their 
levels of evidence.
184
 In 2002, Friedman
182
 published a paper on the prognosis of initial 
treatment and used the accepted guidelines for appraisal of studies.
185
 Friedman grouped 
the appraisal criteria into four parameters: cohort at inception and end-point of study, 
treatment, outcome assessment, and data analysis. Friedman included studies for review 
that included three of the four parameters. The results were divided into several 
categories.  The first regarded treatment outcomes in teeth presenting with no apical 
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periodontitis. These were teeth that might have been diagnosed with irreversible pulpitis, 
necrosis, or inadequate obturation. Large percentages of these teeth maintained periapical 
health after 10 years. It was concluded that these teeth have a 92-percent to 98-percent 
success rate after initial treatment and orthograde retreatment. The second category was 
about treatment outcomes in teeth with apical periodontitis; these were teeth with either a 
primary or secondary infection. There was more variability reported in this section. The 
success rates 10 years post-operative ranged from 73 percent
186
 to 90 percent
187
 for initial 
treatment and 74 percent
188
 to 86 percent
189
 for retreatment. Friedman
181
 states that seven 
studies from initial treatment and one from retreatment showed 88 percent of teeth were 
considered functional with signs of disease healing. A subsequent study by Friedman et. 
al.
190
  estimated that 5 percent of the teeth included in the study were functional with 
disease present, but without symptoms. The percentage of functional teeth included with 
endodontic successes approximates 95 percent.  
Epidemiological studies have shown 97 percent of teeth that were treated by 
NSRCT were clinically present at an eight-year recall. In this study Delta Dental 
reviewed an insurance claim pool of 1,400,000 root canal treated teeth. It was determined 
that 97 percent of those teeth were clinically present after an eight-year follow-up.
191
 In a 
similar study, a pool  of 44,000 patients showed a 94-percent retention rate for 
endodontically treated teeth after a three-and-a-half year follow up.
192
 There has been 
some controversy regarding success of one-visit or two-visit root canal therapy. In a 
recent systematic review by Sathorn et al.,
193
 single-visit root canal treatment appeared to 
be slightly more effective than multiple visits, i.e. a 6.3-percent higher healing rate. 
However, the difference in healing rate between these two treatment regimens was not 
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statistically significant. In summary, NSRCT and surgical endodontics have high success 
rates. To maintain this high success rate, certain preoperative variables and treatment 
techniques need to be taken into consideration to determine successful treatment 
outcomes. 
Initial NSCRT has been shown to be successful; however, failures do occur. 
When failures occur, it is because of persistent infection or secondary infection. Many 
factors can influence a negative outcome, inadequate chemo-mechanical debridement, 
missed canals, irregular anatomy, or poor asepsis protocol.
194
 This pathology can be 
addressed with retreatment or surgical treatment of the periradicular tissues. A systematic 
review by Torabinejad et al.
194
 concluded the literature reports a decreased success rate of 
13 percent to 36 percent on non-surgical retreatment cases with many factors influencing 
the outcomes of the various studies reviewed. Torabinejad et al.
194
 concluded there are 
improved outcomes for non-surgical retreatment with increased recall time and that non-
surgical retreatment is a successful alternative to extraction. In a study by Imura et al.,
195
 
2000 retreatment cases treated by a specialist were evaluated, and the success rate was 
85.9 percent. Overall, the literature supports good success rates for non-surgical 
retreatment in endodontics when thoroughly treated cases are completed. 
The literature determining the success of endodontic surgery is plagued with the 
same challenges as for conventional root canal therapy. Variability in success may be 
attributed to case selection, repeat surgery, quality of previous treatment, and surgical 
technique.
181,183,196-198
 Because of these differences, success of endodontic surgery has 
been reported to be 31 percent
199
 to 91 percent.
198
 After a review of the literature by 
Friedman et. al.,
181
 the functional success rate of teeth after surgery is 86 percent
199
 to 92 
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percent.
200, 
190, 201, 202
  Friedman et al.
183
 concluded that the tooth with apical periodontitis 
remains asymptomatic 91 percent to 97 percent of the time. Recent systematic reviews by 
Setzer and Tsesis emphasize the use of microsurgical techniques, which increased 
surgical success rates to 97 percent.
203
 
Surgical endodontics is indicated when practitioners are presented with these 
situations: failure of NSRCT; retreatment cannot resolve the problem; teeth restored with 
posts; full coverage restorations for which retreatment risks the removal of excessive 
tooth structure, and when there are persistent symptoms.
204
 Since the introduction of 
microsurgical techniques, there has been a marked increase in success rates of surgical 
endodontics.
205, 206
 Several reports have been published reporting the success of surgical 
endodontics. Rubenstein et al.
207
 performed 94 surgical cases with microsurgical 
techniques over a period of 14 months. The cases were followed for 12 months and they 
found a success rate of 96.8 percent with an average healing time of 7.2 months. 
Rubenstein et al.
208
 followed up his short-term study with a 5-year-to-7-year recall and 
found a success rate of 91.5 percent. Christiansen et al.
209
 found similar short-term results 
as Rubenstein using microsurgical techniques. Tsesis et al.
206
 conducted a meta-analysis 
of the literature and concluded that microsurgical endodontics had a successful outcome 
of 91.6 percent at one year. Surgical endodontics is a predictable conservative approach 
to maintaining a healthy dentition after NSRCT and retreatment failure. 
Regenerative endodontics is a new treatment and only case reports currently exist 
in the literature at this time.  The predictability of the success of this procedure has not 
been determined. Only case reports, case series, and controlled animal studies are 
available for review at this time.
4,14,126,136, 210
 However, recent case reports have 
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demonstrated that revascularization of necrotic immature infected root canals is possible 
in vivo.  
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MATERIALS AND METHODS 
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PDS*II (polydioxanone) suture was obtained from Ethicon (Somerville, NJ) and 
was dissolved in 1,1,1,3,3,3-hexafluoro-2-propanol, HFIP (Sigma Aldrich) under stirring 
conditions. Drug-containing polymer solutions were prepared with 5.0-wt % and 25.0- 
wt% metronidazole. The polymer based solutions were mixed together and homogenized 
under vigorous stirring (Figure 3). For each polymer/mixture, the solution was drawn into 
a 5-ml plastic syringe with a blunt-tip needle. This loaded syringe was then placed in an 
electrically grounded (Figure. 1) syringe pump (PHD2000, Harvard Apparatus, MA) and 
the needle connected to a DC voltage power supply (Model ES60P-20W/DAM, Gamma 
High Voltage Research Inc., FL).  
An electrically grounded aluminum foil collector sheet was adequately distanced 
from the tip of the spray needle (Figure 1). The tip of the electrically charged needle and 
the grounded collector sheet were fully enclosed within a clear Lexan box in order to 
minimize influence from air currents. An exhaust hose pulling a weak vacuum was 
attached to the Lexan box to help remove solvent vapors during electrospinning. The 
drug-containing fibers were co-electrospun at optimized conditions (i.e., voltage, 
distance, and flow rate). As control groups, drug-free (0.0 wt %) PDS scaffolds were also 
obtained (Figure 9). The obtained fibrous scaffolds were dried in a desiccator at room 
temperature for at least 48 h to remove the residual solvent.  
 
MODIFIED DIRECT CONTACT TEST (MDCT)  
The MDCT (Figure 8) was used to assess the antimicrobial effect of the drug-
containing scaffolds by turbidimetric determination of bacterial growth. Given the 
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antibiotic was in the scaffold, we indirectly brought the bacteria into contact with the 
scaffold in the broth. It was expected the antibacterial effect would be a result of the 
antibiotic being released from the scaffold into the surrounding broth. Bacterial growth is 
observed through changes in absorbance. The effect of the antibiotic was determined by 
turbidimetric analysis of bacterial growth at 37C for testing to determine bacterial 
growth. The microplate reader uses a light source that transilluminates the sample with a 
predetermined wavelength, and a light detector on the opposite side of the well measures 
the quantity of the light transmitted through the sample. A smaller amount of light 
transmitted correlates with a higher density of bacterial cells. The electrospun scaffolds 
were collected onto an aluminum foil sheet and subsequently cut into 4 mm diameter 
sections (Figure 10). The aluminum foil was separated from the scaffold and the scaffold 
was placed at the bottom of the microwell in the flat bottom microtiter plate. P. gingivalis 
was cultured for 48 hours in Brain Heart Infusion (BHI) broth containing yeast extract 
and 0.25 ml of vitamin K at 37C in anaerobic conditions (Figure 12, 17). Bacterial 
growth was confirmed by turbidity in the broth.  One hundred ninety (190) µl of the non-
inoculated BHI with yeast extract was added to each well and 10 μl of the 48-h bacterial 
suspension (approximately 10
6
 bacteria) was placed in the microwells (Figure 13). The 
prepared microplates were incubated under anaerobic conditions for 48 h. After the 48-h 
incubation period the microplates were removed from the GasPack (Figure 16) and the 
scaffolds were carefully removed with sterile instruments to prevent cross-contamination 
of the microwells. Spectrophotometry was done by measuring the optical density at 595 
nm using an endpoint reading with the spectrophotometer set to 37C. 
 Controls consisted of: 
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1. Negative control:  Untouched walls of microwell with non-inoculated 
medium (n = 8 wells). 
2. Negative control: Walls of microwell coated with scaffold with non-
inoculated medium (n = 8).  
3. Positive control: Untouched microwell with inoculated medium (n=8).  
Experimental groups consisted of:  
4. PDS scaffolds with no antibiotic and inoculated with P. gingivalis media 
(n = 8).  
5. PDS scaffolds containing 5.0-wt % MET and inoculated with P. gingivalis 
media (n = 8).  
6. PDS scaffolds containing 25-wt % MET and inoculated with P. gingivalis 
media (n = 8).  
Each experiment was conducted three times.  
 
STATISTICAL ANALYSIS 
Comparisons among the groups for differences in optical density as a measure of 
bacterial growth were made using mixed-model ANOVA, with a fixed effect for group 
and a random effect for experimental run. Pair-wise group comparisons were performed 
using Tukey's multiple comparisons procedure to control the overall significance level at 
5 percent. The analyses were performed using the ranks of the data.  
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RESULTS 
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Optical density (OD) is a measurement of the turbidity of a solution. In our 
experiment uninoculated BHI+YE broth showed a significantly lower OD at 595 nm than 
all other groups (p < 0.0001) indicating that the broth had no turbidity at the time of the 
reading, which confirmed no bacterial growth in our negative controls (Figure 4 to Figure 
6).  
BHI+YE+Pg and BHI+YE+Pg + control scaffold (no antibiotic) showed a 
significantly higher OD at 595 nm confirming positive bacterial growth in our positive 
controls. This growth was significantly more than growth measured in the scaffolds 
containing 5.0 wt % and 25 wt % (p < 0.0001 and p < 0.0001), respectively. Less 
bacterial growth was seen in the groups containing the MET incorporated into the 
scaffold indicating that the scaffold was effective at inhibiting bacterial growth (Figure 4 
through Figure 6). 
However, the 5.0-wt % and 25-wt % MET were not significantly different from 
each other (p = 0.21) indicating that the higher concentration of MET used in this study 
was not more beneficial than the lower concentration. The concentrations used in this 
study were well above the MIC for metronidazole against Pg reported in the literature to 
be 0.122 µl.
211
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FIGURES  
 
 
 
 
 
 
  
49 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
FIGURE 1. Schematic of the electrospinning set-up used to obtain the nanofibrous 
structures. The PDS solution and PDS solution + metronidazole were 
loaded into the syringe. The solution was expressed through the needle at a 
predetermined rate with a specific voltage attached to the needle. The 
electrospun polymer was collected on a grounded collector with aluminum 
foil at a predetermined distance. 
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FIGURE 2.   Representative scanning electron microscopy (SEM) images of an 
electrospun scaffold containing metronidazole. The image shows the 
individual distribution of each electrospun nanofibers and their spatial 
relationships at a measurement of 10 μm. 
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FIGURE 3. Clear PDS II
® 
pieces were dissolved overnight in HFP under stirring 
conditions. PDS solution was then loaded with 2 distinct amounts of 
metronidazole-MET (i.e., 5.0 wt % and 25 wt % respective to the total 
polymer weight). The 3 different solutions (i.e., control, PDS +5.0 wt % 
MET and PDS + 25 wt % were individually loaded into 5-ml plastic 
syringes fitted with a 27-gauge stainless steel needle and electrospun at 
optimized conditions. 
 
 
  
 
  
 
 
Dissolving in HFIP 
10 % (w/v) 
Overnight 
stirring - RT 
PDS in HFIP (100 mg ml
-1
) 
+ 5.0-wt % MET 
+ 25-wt % MET 
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FIGURE 4. Graph representing experiment #1. The x-axis shows optical density 
measured at 595 nm and y-axis shows experimental groups tested. No 
bacterial growth was measured in the negative control group. Significant 
growth was measured in broth + Pg and broth + control scaffold + Pg 
groups. Groups containing 5.0% wt. and 25% wt. showed significant Pg 
inhibition compared with positive control groups. 
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FIGURE 5. Graph representing experiment #2. The x-axis shows optical density 
measured at 595 nm and y-axis shows experimental groups tested. No 
bacterial growth was measured in the negative control group. Significant 
growth was measured in broth + Pg and broth + control scaffold + Pg 
groups. Groups containing 5.0% wt. and 25% wt showed significant Pg 
inhibition compared with positive control groups.  
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FIGURE 6.  Graph representing experiment #3. The x-axis shows optical density 
measured at 595 nm and y-axis shows experimental groups tested. No 
bacterial growth was measured in the negative control group. Significant 
growth was measured in broth + Pg and broth + control scaffold + Pg 
groups. Groups containing 5.0% wt. and 25% wt. showed significant Pg 
inhibition compared with positive control groups. 
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FIGURE 7. Graph combining all three experiments. The x-axis shows optical density 
measured at 595 nm and y-axis shows all three experimental groups 
tested. Group 1 (black) represents experiment #1. Group 2 (grey) 
represents experiment #2. Group 3 (charcoal) represents experiment #3. 
The results of all three experiments were compared, and the negative 
controls in all three groups showed no Pg growth. All three groups 
showed Pg growth in the positive control groups. The groups with the 
metronidazole containing scaffold at 5.0% wt and 25% wt showed 
significant Pg inhibition in all three groups.  
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FIGURE 8.  Representation and explanation of experimental groups placed in 
microwells in this study. 
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FIGURE 9. Electrospun scaffold on aluminum foil after being collected on aluminum 
foil during the electrospinning process. This shows an unused section of 
scaffold used in this experiment. 
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FIGURE 10. A biopsy punch 4 mm in diameter was used to cut all the experimental 
scaffolds from the aluminum foil collector. After the cutting, the 
aluminum foil was removed and the scaffold was placed in an air tight 
container and stored in a desiccator until used in the experiment. 
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FIGURE 11.  A 96-well microtiter plate used for our experiment obtained from Fisher 
Scientific.  
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FIGURE 12.  GasPack used to maintain anaerobic conditions during cultivation of Pg. 
After assembly the GasPack was placed in an incubator for 48 hours. 
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FIGURE 13.  Prepared microplate with all experimental groups present as represented 
in FIGURE 8.  
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FIGURE 14.  Image of electrospinning apparatus used in this project located in the 
dental materials department of IUSD. 
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FIGURE 15.  A 10-mm zone of inhibition seen around cyanoacrylate on cultured plate 
indicating that cyanoacrylate has antimicrobial properties and is not a 
suitable material to use in the microwells of this experiment. 
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FIGURE 16.  Microplates in GasPack container to maintain anaerobic conditions. 
GasPack container was sealed for 48 hours and incubated before 
spectrophotometer reading. 
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FIGURE 17.  Prepared Pg in BHI + YE broth after 48 hour incubation in GasPack to 
maintain anaerobic conditions. Visual turbidity confirms the growth of Pg. 
These bacteria were then used in experimental microwells. 
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DISCUSSION 
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Polydioxanone was successfully electrospun with metronidazole to form a 
synthetic polymer scaffold. The results show that the scaffold is capable of inhibiting 
bacterial growth in vitro. Our results confirm results from other studies that incorporated 
antibiotics into electrospun fibers.
1,19,106
 The present study is the first report that we are 
aware of introducing an electrospun scaffold containing antibiotics to be used as a drug 
delivery device for the endodontic regeneration procedure.   
PDS II (polydioxanone) is a colorless bioabsorbable monofilament polymer 
commonly used as a suture material.
212
 In  this study PDS II was selected  because it has 
many desirable properties for a scaffold material. Also, polymer scaffolds have been 
reported in the literature to perform as functional scaffolds for pulp fibroblast seeding, 
proliferation, and differentiation.
213
 PDS biodegrades into water and carbon dioxide, 
which are easily disposed of by the body resulting in a low inflammatory response and 
host acceptance.
212
 When scaffold remnants persist, they can negatively affect the 
outcome by creating a foreign body response.
1
 PDS II naturally has a slow 
biodegradation time, which can be manipulated by electrospinning. It is important to not 
have the scaffold degrade too early as this has negative effects on mechanical properties 
and stability.
1
 Currently, synthetic electrospun polymeric nanofibers are under 
investigation for drug delivery devices in medicine and other applications for tissue 
engineering.
106
 
The agar diffusion test (ADT) is the standardized method to test for antibiotic 
susceptibility.
178,214
 With this test antibiotic-containing discs are placed on agar plates 
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containing bacteria. When a clear zone around the plate is present, bacterial inhibition is 
represented, and the effectiveness of the antibiotic can be tested against specific 
microorganisms. ADT is not a predictable test for the antimicrobial effectiveness of 
endodontic disinfecting agents or intracanal medicaments because of the differences 
between the infected root canal system and the agar. The DCT is an alternative method to 
test antimicrobial activity of restorative material and endodontic sealers.
178,179,214
 
The selection of antibiotics to treat an infection should be based on the most 
current knowledge available to successfully treat an infection. Since the majority of 
bacteria located deep in dentinal tubules are obligate anaerobes, metronidazole was 
selected as the test drug.
118
 It is well established in the literature that metronidazole is 
effective and has a wide spectrum against gram-negative anaerobes.
21
 Intraorally, 
metronidazole has been shown to have bactericidal action against oral obligate anaerobes, 
anaerobes from infected pulps, and in 99 percent of bacteria in carious lesions.
118
 
Metronidazole exerts its effect by deactivating critical enzymes intracellularly once inside 
the bacteria and is bactericidal.
215
  
Currently, the regenerative endodontic procedure uses a triple antibiotic paste 
(TAP) that is introduced into the canal for disinfection.
4,9,17,136,216
 Recent case reports and 
studies have demonstrated the effectiveness of  TAP when used as a canal disinfectant in 
the regenerative procedure; however, it is still unknown what the effective concentrations 
of the antibiotics are for this procedure. Currently, a mixture of 200 mg of ciprofloxacin, 
500 mg metronidazole, and 100 mg of minocycline is reported in the literature.
217
 Drug 
sensitivity is usually determined by finding the MIC (minimum inhibitory concentration); 
however, so many bacterial species are found in endodontic lesions and in the oral cavity, 
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it would be impossible to determine the MIC for every bacteria present.
119
 The reported 
MIC for metronidazole is 0.122 µl for P. gingivalis.
211
 A reduced known effective 
concentration would be beneficial to reduce the overuse of antibiotics. This was 
addressed by starting with specific concentrations of metronidazole in the scaffolds (5.0 
wt % and 25 wt %) that are well above the MIC for metronidazole. The MIC in this study 
was found to be 0.134 µl, which is not significantly different than a previous study which 
was 0.125 µl.
218
  In addition, whether higher levels of antibiotics incorporated into the 
scaffold would be of any benefit was evaluated. The results indicated there was no 
significant difference between the 5.0-wt % and 250-wt % concentrations; both 
effectively inhibited bacterial growth. These results confirm the reported effectiveness in 
the literature of an electrospun scaffold capable of drug release.
1,19,106
 An electrospun 
scaffold with antibiotic incorporated could be used as a drug delivery device for canal 
disinfection.   
For the TAP to be effective, it must be in contact with dentin.
135
 It is clinically 
impossible to confirm that the TAP is adapted to the canal walls since it is not 
radiopaque. This also presents a problem on the required second visit to remove the paste. 
It is difficult to determine if all the paste is removed. A recent report found that TAP is 
not toxic by histological examination; however, the vehicle used to deliver the TAP 
(propylene glycol) may be difficult to remove from the dentin surface potentially altering 
the regeneration potential. The second visit to remove the TAP also introduces risk of 
recontamination if good isolation is not obtained. 
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A better understanding of effective antibiotic concentrations and or the use of 
single or multiple antibiotics, distribution, and vehicles for delivery is necessary for 
efficient disinfection would improve the suggested current treatment protocol.  
Other scaffolds have been investigated to improve the regenerative procedure, the 
most recent being an injectable hydrogel scaffold. Hydrogels are three-dimensional and 
can be delivered by syringe. In theory, they would provide a substrate for cell 
proliferation and differentiation. However, progress has been halted by their ability to 
support cell survival; the mechanical properties are not ideal and degradation is rapid.
4
 
Platelet rich plasma (PRP) is also currently being investigated as a scaffold material. It 
fulfills much of the criteria for a scaffold: it is rich in growth factors, biodegradable, 
forms a three-dimensional matrix, and is autologous.
9
  Research is now focusing on 
making them more rigid to support cell growth. Polymer electrospun scaffolds are 
currently attractive for tissue engineering due to their desirable properties; they have 
already been approved by the FDA for patient use and their ability to incorporate 
bioactive molecules.
219 
Many of the current challenges with the regenerative procedure could be 
addressed with a drug incorporated electrospun polymer scaffold. As shown in the 
current study, it can serve in vitro as a drug delivery device, using specific predetermined 
amounts of antibiotic. A unique feature of polymeric nanofibers is the high surface area 
of the fibers arranged in a interconnecting structure that allows controlled drug release.
106
 
As the scaffold degrades over time, the drug is released giving an ideal dose in time.
219
 
Also, the drug release can be manipulated to be rapid, intermediate, delayed, or modified 
depending on the polymer used.
110
 These advantages can improve drug delivery, reduce 
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appointments, and improve drug adaptation to the canal wall in the regeneration 
procedure. 
In a pilot study, the scaffold was attached to the microwell wall with OptiBond 
and cyanoacrylate. By attaching the scaffold to the microwell, it would not interfere with 
the optical density reading. However, by attaching the scaffold with the aluminum foil 
still attached only one side would be available for MET release. OptiBond was unable to 
secure the scaffold to the wall during the sterilization process. Cyanoacrylate was used, 
and it successfully secured the scaffold to the wall for the duration of the experiment. 
However, upon interpreting the results, the cyanoacrylate control showed bacterial 
inhibition (Figure 15). It was impossible to determine what kind of efficacy the scaffold 
had against bacteria while using cyanoacrylate. Subsequently, it was decided to separate 
the scaffold from the aluminum foil and place the scaffold in the microwell unbounded to 
any wall. The scaffold was carefully removed with sterile instruments and the plate read. 
This proved to be the best way to test the scaffold’s in-vitro effectiveness. 
Although metronidazole is effective against obligate anaerobes, even at high 
concentrations, it has been shown that it cannot eliminate all the bacteria in a necrotic 
root canal.
118
 However, when combined with multiple drugs such as the TAP, it has been 
reported that TAP can sterilize a root canal.
119,135
 Future studies could incorporate other 
antibiotics, individually and combined, into the scaffold for bacterial testing. Other 
bioactive molecules such as growth factors could be included to improve the scaffold’s 
tissue regenerative properties.  
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Future studies could include the incorporation of multiple antibiotics, evaluation 
for interim root canal dressing, incorporation of bioactive molecules, and animal studies 
for effectiveness of the scaffold.  
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SUMMARY AND CONCLUSIONS 
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Our null hypothesis was accepted as P. gingivalis was significantly inhibited by 
the PDS electrospun scaffold. 
The PDS scaffold used in this study can function as an antibacterial drug delivery 
device against anaerobic bacteria. The 5.0-wt % should be considered for use to avoid 
excess antibiotic use since there was not a statistical difference from the 25-wt %.  
This scaffold could potentially improve the regenerative endodontic procedure by 
providing a predictable scaffold for growth, sustained antibiotic release, controllable drug 
concentrations, and eliminating a step in the regenerative procedure. 
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ANTIMICROBIAL PROPERTIES OF DRUG-CONTAINING 
ELECTROSPUN SCAFFOLDS 
 
 
 
 
by 
 
John Jeppson  
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Indianapolis, IN 
 
Endodontic treatment of the infected immature tooth has undergone a dramatic 
change. Conventional endodontic treatment can control infection, but root development 
usually remains impaired. A novel regenerative endodontic procedure, the 
revascularization method, can now control the infection and enable such teeth to continue 
root development. This is done by creating a fibrin-matrix scaffold in the antibiotic 
treated root canal space (RCS).  Dental stem cells and growth factors have been able to 
continue root development in such an environment. The fibrin-matrix scaffold is 
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dependent on the induction of a blood clot into the RCS, and this cannot always be 
predictably induced. PDS is a biocompatible material that can be electrospun to provide a 
matrix for cells and growth factors and perhaps improve on the blood clot induced fibrin 
scaffold by incorporating metronidazole as an adjuvant antimicrobial. A metronidazole 
containing electrospun PDS scaffold was examined in vitro using a turbidimetric test, the 
modified direct contact test. This scaffold significantly inhibited growth of an anaerobic 
primary endodontic pathogen Porphyromonas gingivalis. This scaffold may improve the 
treatment of the infected immature tooth by providing a designed matrix for root 
regeneration while serving simultaneously as an antibiotic drug delivery device to 
disinfect the RCS.  
The aim of this study is to evaluate in vitro the property of a synthetic scaffold to 
function as an antibacterial drug delivery device. 
PDS*II (polydioxanone) suture was obtained from Ethicon, INC. (Somerville, NJ) 
and was dissolved in 1,1,1,3,3,3-hexafluoro-2-propanol, HFIP (Sigma Aldrich). Three 
different scaffolds were electrospun onto an aluminum foil background; (1) control 
scaffold with no antibiotic incorporated, (2) scaffold with 5.0-wt % metronidazole 
incorporated, and (3) 25-wt % metronidazole incorporated. All scaffolds were cut using a 
4-mm diameter biopsy punch under aseptic conditions and removed from foil, control 
scaffold (n = 64), scaffold containing 5.0-wt % metronidazole (n = 32), and scaffold 
containing 25-wt % metronidazole (n=32). Experimental scaffolds were placed in a 96- 
well sterile flat bottom microtiter plate. Porphyromonas gingivalis a known primary 
endodontic pathogen was grown in 5 ml of BHI + YE with 0.25 μl of vitamin K with 
incubation at 37°C under anaerobic conditions for 48 hours. Microplates were sterilized 
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before inoculation with Pg with 400 μl of 70-percent EtOH for a minimum of 30 minutes 
then pipetted out. After sterilization the microwells were washed with 400 μl of sterile 
water and pipetted out. Group 1 (negative control) microwells (n = 8) contained control 
scaffold and 190 μl of broth only. Group 2 (positive control) microwells (n = 8) contained 
190 μl of broth and Pg only. Group 3 microwells (n = 8) contained control scaffold, 190 
μl of broth, and 10 μl of Pg inoculum. Group 4 microwells (n = 8) contained scaffold 
with 5 wt % metronidazole, 190 μl of broth, and 10 μl of Pg inoculum. Group 5 
microwells (n = 8) contained scaffold with 25 wt % metronidazole, 190 μl of broth, and 
10 μl of Pg inoculum. Group 6 contained 190 μl of uninoculated broth for 
spectrophotometer calibration. Sterile microplate lids were used to isolate microwells 
from the surrounding environment. Microplates were incubated at 37°C under anaerobic 
conditions for 48 hours. After 48 hours the microplates were read by using an endpoint 
reading in the spectrophotometer. This was repeated four times. 
Comparisons among the groups for differences in optical density as a measure of 
bacterial growth were made using mixed-model ANOVA, with a fixed effect for group 
and a random effect for experimental run. Pair-wise group comparisons were performed 
using Tukey's multiple comparisons procedure to control the overall significance level at 
5 percent. The analyses were performed using the ranks of the data. Broth had 
significantly lower OD than all other groups (p < 0.0001). Broth+Pg and 
Broth+Pg+Scaffold had significantly higher OD than 5-wt % Metro (p < 0.0001) and 25-
wt % Metro (p < 0.0001), but Broth+Pg and Broth+Pg+Scaffold were not significantly 
different from each other (p = 0.97). 5-wt % Metro and 25-wt % Metro were not 
significantly different from each other (p = 0.24). 
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From the results of our study, we concluded that the 5.0-wt % and 25-wt % 
metronidazole containing scaffolds significantly inhibited bacterial growth and could be 
effectively utilized for the endodontic regeneration procedure.  
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